Book Cardiolipin Antibody aCL-IgA Test Online At 30 % Off

Cardiolipin Antibody aCL - IgA Test and its Function

The Cardiolipin Antibody (aCL) - IgA test is a laboratory test used to measure the levels of IgA antibodies against cardiolipin in the blood. Cardiolipin is a phospholipid found in the inner mitochondrial membrane and other cellular membranes. The test is primarily performed to evaluate the presence of aCL antibodies, which are associated with certain autoimmune disorders and an increased risk of blood clotting.

Conditions that may require Cardiolipin Antibody aCL - IgA Test

Antiphospholipid Syndrome (APS): The test is commonly used to diagnose APS and assess its severity. Elevated levels of aCL antibodies, including IgA, are one of the diagnostic criteria for APS.
Systemic Lupus Erythematosus (SLE): SLE is an autoimmune disease that can be associated with the presence of aCL antibodies. The test may be used in the evaluation of patients with SLE to assess the risk of APS and related complications.
Other Autoimmune Disorders: aCL antibodies can sometimes be detected in individuals with other autoimmune disorders, such as rheumatoid arthritis or Sj??gren's syndrome. Testing for aCL antibodies may be considered in specific clinical situations to evaluate the risk of thrombosis.

Cardiolipin Antibody aCL - IgA Test Procedure

The Cardiolipin Antibody aCL - IgA Test is a simple blood test that can be performed in a laboratory. Before the test, the patient may be asked to avoid certain medications that may affect the results. During the test, our healthcare professional will use a needle to draw blood from a vein in the patient's arm. The blood sample will then be sent to our laboratory for analysis.

Interpreting Cardiolipin Antibody aCL - IgA Test Results

Interpreting Cardiolipin Antibody (aCL) - IgA test results involves comparing the measured levels of IgA antibodies against cardiolipin with established reference ranges. Elevated levels of aCL antibodies, particularly IgA, can indicate an increased risk of clotting and the presence of an underlying autoimmune condition such as APS.